MedPath
NMPA Approval

Levothyroxine Sodium Tablets

国药准字J20160066

MERCK KGAA

July 31, 2019

H20140051

Drug Information

左甲状腺素钠片

优甲乐

片剂

100μg(以左甲状腺素钠计)

化学药品

July 31, 2019

Company Information

Applicant Company

MERCK KGAA

Alsfelder Straβe 17 64289 Darmstadt Germany

Manufacturing Company

MERCK KGAA

Frankfurter Straβe 250 64293 Darmstadt Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左甲状腺素钠片 - NMPA 批准文号 | MedPath